Stock Events

Stock Events

Search...

Adaptimmune Therapeutics (ADAP) Q3 2024 Earnings

13NovConfirmed

Q4 2023

Q1 2024

Q2 2024

Q3 2024

-0.24

-0.08

0.08

0.24

Details

Expected EPS

-0.13

Actual EPS

-0.07

Surprise EPS

0.06

Surprise Percent

+46.15%

Description

Adaptimmune Therapeutics (ADAP) has reported earnings of -0.07 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.